Fresh analysis suggests that individuals who come off popular slimming jabs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Published data in a leading medical journal shows that while obese individuals frequently drop substantial amounts of their total mass while on the medication, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"People purchasing such medications must be aware of the potential of rapid rebound weight gain when the medication ends," stated lead investigator Dr. Susan Jebb.
That rate of recovery means a return to pre-treatment weight within about one and a half years.
Analyzing Treatments
The study, which reviewed 37 of trials involving thousands of participants, contrasted the results of the injectable medications with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise generally see a slower weight regain—approximately 0.1 kg a month—once they finish.
Understanding the Quick Rebound
Doctors propose the way of the injections is key to understanding the amplified rebound.
These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels far above than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication results in hunger is unsuppressed, making overeating a significant risk."
An Ongoing Condition?
Health authorities recommend the jabs for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians argue that, considering the high risk of weight regain, the treatment should be considered life-long.
This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent character of obesity," similar to managing diseases like high blood pressure.
User Experiences
Individuals who have come off the medication report a intense return of appetite.
"I experienced something activating and you become extremely hungry," said a patient.
This difficulty is compounded if users have not adopted sustainable dietary or behavioural changes during therapy.
Significant Adoption
Recent estimates show that millions of adults in the UK have used these injections in the past year, with interest remaining high.
- Adoption is more common among females than males.
- The middle-aged demographic shows the highest level of interest.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while these medications are effective tools for shedding pounds, they are not a magic cure and maintained weight loss likely depends on integrated behavioural changes.
